机构地区:[1]The Second Department of General Surgery,The Fourth Hospital of Hebei Medical University,Shijiazhuang,Hebei 050001,China [2]Department of Colorectal Surgery,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China [3]Department of Medical Oncology,The Fourth Hospital of Hebei Medical University,Shijiazhuang,Hebei 050001,China [4]Department of Cancer Institute,The Fourth Hospital of Hebei Medical University,Shijiazhuang,Hebei 050001,China [5]Department of Pediatrics,The Fourth Hospital of Hebei Medical University,Shijiazhuang,Hebei 050001,China [6]Department of General Surgery,The Second Hospital of Hebei Medical University,Shijiazhuang,Hebei 050050,China
出 处:《Chinese Medical Journal》2023年第7期830-839,共10页中华医学杂志(英文版)
基 金:Youth Science and Technology Project of Hebei Health Commission(No.20210029);Hebei Provincial Natural Science Foundation Precision Medicine Joint Project(No.H2020206485);Hebei Provincial Department of Science and Technology Key Project(No.206Z7705G)
摘 要:Background:The effect of intra-operative chemotherapy(IOC)on the long-term survival of patients with colorectal cancer(CRC)remains unclear.In this study,we evaluated the independent effect of intra-operative infusion of 5-fluorouracil in combination with calcium folinate on the survival of CRC patients following radical resection.Methods:1820 patients were recruited,and 1263 received IOC and 557 did not.Clinical and demographic data were collected,including overall survival(OS),clinicopathological features,and treatment strategies.Risk factors for IOC-related deaths were identified using multivariate Cox proportional hazards models.A regression model was developed to analyze the independent effects of IOC.Results:Proportional hazard regression analysis showed that IOC(hazard ratio[HR]=0.53,95%confidence intervals[CI][0.43,0.65],P<0.001)was a protective factor for the survival of patients.The mean overall survival time in IOC group was 82.50(95%CI[80.52,84.49])months,and 71.21(95%CI[67.92,74.50])months in non-IOC group.The OS in IOC-treated patients were significantly higher than non-IOC-treated patients(P<0.001,log-rank test).Further analysis revealed that IOC decreased the risk of death in patients with CRC in a non-adjusted model(HR=0.53,95%CI[0.43,0.65],P<0.001),model 2(adjusted for age and gender,HR=0.52,95%CI[0.43,0.64],P<0.001),and model 3(adjusted for all factors,95%CI 0.71[0.55,0.90],P=0.006).The subgroup analysis showed that the HR for the effect of IOC on survival was lower in patients with stage II(HR=0.46,95%CI[0.31,0.67])or III disease(HR=0.59,95%CI[0.45,0.76]),regardless of pre-operative radiotherapy(HR=0.55,95%CI[0.45,0.68])or pre-operative chemotherapy(HR=0.54,95%CI[0.44,0.66]).Conclusions:IOC is an independent factor that influences the survival of CRC patients.It improved the OS of patients with stages II and III CRC after radical surgery.Trial registration:chictr.org.cn,ChiCTR 2100043775.
关 键 词:Colorectal cancer Intra-operative chemotherapy Overall survival Retrospective cohort study Stage
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...